Investment Summary

Eight Roads Invests In Amphora Medical

On January 1, 2013, private equity firm Eight Roads invested in medical products company Amphora Medical

Investment Highlights
  • This is Eight Roads’ 5th transaction in the Medical Products sector.
  • This is Eight Roads’ 24th transaction in the United States.
  • This is Eight Roads’ 1st transaction in Minnesota.
Investment Fate
  • Amphora Medical was sold to a publicly-traded strategic buyer in 2019.

Investment Summary

Date 2013-01-01
Target Amphora Medical
Sector Medical Products
Investor(s) Eight Roads
Deal Type Venture

Target

Amphora Medical

Maple Grove, Minnesota, United States
Amphora Medical is a developer of medical devices and instruments. The company is currently working on a novel cystoscopic device that has the potential to improve bladder function and quality of life for people with Overactive Bladder Syndrome (OAB). Amphora Medical is based in Maple Grove, Minnesota.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 59 of 293
Sector: Medical Products M&A 5 of 15
Type: Venture M&A Deals 46 of 266
State: Minnesota M&A 1 of 2
Country: United States M&A 24 of 120
Year: 2013 M&A 4 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-01 Flywire Payments

Boston, Massachusetts, United States

Flywire Payments is a provider of global payment and receivables solutions, connecting over 1,400 businesses and institutions with their customers on six continents. The company processes billions in payments per year from 220 countries and territories, via bank transfer, credit card and e-wallet solutions, in over 120 different local currencies. Flywire’s scalable platform provides currency conversion at exchange rates that can offer significant savings when compared to home-market banks and credit card providers. The company also supports its clients with end-to-end customer support including multilingual servicing via phone, email, and chat, as well as 24/7 online payment tracking. Flywire Payments was founded in 2009 and is headquartered in Boston, Massachusetts with operations in London and Manchester, UK; Shanghai, China; Tokyo, Japan; Singapore; Sydney, Australia; and Valencia, Spain.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-11 Richcore Lifesciences

Bangalore, India

Richcore Lifesciences is an innovation-driven company focused on development and manufacture of industrial enzymes that have global relevance. Richcore Lifesciences was founded in 2005 and is based in Bengaluru, India.

Buy -